Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Cytotoxic | 4 | 2022 | 170 | 1.850 |
Why?
|
| Intubation, Intratracheal | 7 | 2013 | 93 | 1.520 |
Why?
|
| Cell Surface Display Techniques | 2 | 2019 | 4 | 1.460 |
Why?
|
| Antigens, CD | 4 | 2021 | 317 | 1.250 |
Why?
|
| Antigens, Neoplasm | 4 | 2021 | 109 | 1.250 |
Why?
|
| Single-Chain Antibodies | 4 | 2022 | 8 | 0.910 |
Why?
|
| Analgesia, Obstetrical | 6 | 2002 | 18 | 0.810 |
Why?
|
| Analgesia, Epidural | 6 | 2002 | 27 | 0.810 |
Why?
|
| Receptors, Antigen, T-Cell | 7 | 2012 | 256 | 0.770 |
Why?
|
| Anesthesia, Spinal | 4 | 2011 | 18 | 0.760 |
Why?
|
| Antibodies | 1 | 2019 | 171 | 0.760 |
Why?
|
| Neoplasms | 4 | 2022 | 919 | 0.750 |
Why?
|
| Needles | 3 | 2011 | 46 | 0.720 |
Why?
|
| Fentanyl | 7 | 2002 | 49 | 0.710 |
Why?
|
| Anesthesia, Obstetrical | 4 | 2001 | 26 | 0.620 |
Why?
|
| Chemokines | 1 | 2015 | 84 | 0.600 |
Why?
|
| Mutagenesis | 1 | 2015 | 135 | 0.600 |
Why?
|
| Molecular Biology | 1 | 2015 | 66 | 0.580 |
Why?
|
| Anesthesia, Epidural | 4 | 2001 | 24 | 0.560 |
Why?
|
| Bupivacaine | 4 | 2008 | 31 | 0.560 |
Why?
|
| Complementarity Determining Regions | 5 | 2020 | 33 | 0.560 |
Why?
|
| Bronchoscopes | 2 | 2006 | 6 | 0.550 |
Why?
|
| Inhalation | 1 | 2013 | 6 | 0.550 |
Why?
|
| Respiratory Sounds | 1 | 2013 | 18 | 0.540 |
Why?
|
| Anesthetics, Local | 3 | 2008 | 53 | 0.500 |
Why?
|
| Infant, Premature | 1 | 2013 | 131 | 0.490 |
Why?
|
| Labor, Obstetric | 4 | 2000 | 27 | 0.470 |
Why?
|
| Cell Line, Tumor | 5 | 2022 | 1174 | 0.440 |
Why?
|
| Analgesics, Opioid | 4 | 2002 | 336 | 0.410 |
Why?
|
| Humans | 40 | 2022 | 48011 | 0.360 |
Why?
|
| Anesthesiology | 2 | 2006 | 46 | 0.350 |
Why?
|
| Peptides | 3 | 2008 | 501 | 0.330 |
Why?
|
| Peptide Library | 5 | 2014 | 34 | 0.310 |
Why?
|
| Amino Acid Sequence | 7 | 2019 | 1576 | 0.310 |
Why?
|
| Fiber Optic Technology | 2 | 2006 | 18 | 0.310 |
Why?
|
| Protein Binding | 7 | 2021 | 1533 | 0.290 |
Why?
|
| Laryngeal Masks | 1 | 2004 | 7 | 0.290 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2015 | 495 | 0.280 |
Why?
|
| Sufentanil | 4 | 2000 | 8 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 151 | 0.280 |
Why?
|
| Antigens | 2 | 2019 | 146 | 0.270 |
Why?
|
| Ligands | 4 | 2015 | 391 | 0.260 |
Why?
|
| Solubility | 2 | 2021 | 170 | 0.250 |
Why?
|
| Cesarean Section | 2 | 2000 | 77 | 0.240 |
Why?
|
| Respiration, Artificial | 1 | 2004 | 214 | 0.240 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2001 | 5 | 0.240 |
Why?
|
| Labor Stage, First | 1 | 2001 | 7 | 0.240 |
Why?
|
| Primary Cell Culture | 1 | 2022 | 71 | 0.240 |
Why?
|
| Healthy Volunteers | 1 | 2022 | 69 | 0.240 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 58 | 0.230 |
Why?
|
| HEK293 Cells | 2 | 2022 | 507 | 0.230 |
Why?
|
| Gene Library | 1 | 2022 | 96 | 0.230 |
Why?
|
| Clone Cells | 1 | 2021 | 106 | 0.230 |
Why?
|
| Equipment Failure | 4 | 2011 | 38 | 0.230 |
Why?
|
| Radioimmunotherapy | 1 | 2020 | 5 | 0.230 |
Why?
|
| Lidocaine | 2 | 1998 | 25 | 0.220 |
Why?
|
| Epinephrine | 2 | 1998 | 46 | 0.220 |
Why?
|
| Binding Sites | 4 | 2015 | 849 | 0.220 |
Why?
|
| Crystallography, X-Ray | 4 | 2014 | 379 | 0.220 |
Why?
|
| Immunoconjugates | 1 | 2020 | 55 | 0.220 |
Why?
|
| Protein Multimerization | 1 | 2021 | 149 | 0.220 |
Why?
|
| Spinal Puncture | 1 | 2000 | 15 | 0.210 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 22 | 0.210 |
Why?
|
| Cervix Uteri | 1 | 2000 | 61 | 0.210 |
Why?
|
| Headache | 1 | 2000 | 44 | 0.210 |
Why?
|
| Tyrosine | 1 | 2000 | 81 | 0.210 |
Why?
|
| Cell Line | 3 | 2019 | 1950 | 0.200 |
Why?
|
| Immunotherapy | 2 | 2019 | 193 | 0.200 |
Why?
|
| Protein Domains | 1 | 2019 | 121 | 0.190 |
Why?
|
| Alanine | 2 | 2015 | 46 | 0.190 |
Why?
|
| Major Histocompatibility Complex | 3 | 2011 | 86 | 0.190 |
Why?
|
| Escherichia coli | 3 | 2019 | 667 | 0.190 |
Why?
|
| Pregnancy | 9 | 2002 | 1935 | 0.190 |
Why?
|
| Internship and Residency | 1 | 2004 | 577 | 0.180 |
Why?
|
| Epitopes | 1 | 2019 | 290 | 0.180 |
Why?
|
| Female | 16 | 2021 | 26207 | 0.180 |
Why?
|
| Computer Simulation | 2 | 2020 | 406 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 442 | 0.170 |
Why?
|
| Anesthesia, Closed-Circuit | 1 | 1997 | 1 | 0.170 |
Why?
|
| Sacrum | 2 | 2008 | 15 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2012 | 633 | 0.170 |
Why?
|
| United States Food and Drug Administration | 1 | 1997 | 80 | 0.160 |
Why?
|
| Rhizobium leguminosarum | 1 | 1996 | 1 | 0.160 |
Why?
|
| Acetyltransferases | 1 | 1996 | 35 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2008 | 121 | 0.160 |
Why?
|
| Alveolar Bone Loss | 1 | 1995 | 2 | 0.150 |
Why?
|
| Mandibular Diseases | 1 | 1995 | 2 | 0.150 |
Why?
|
| Cloning, Molecular | 1 | 2015 | 373 | 0.150 |
Why?
|
| Receptors, Chemokine | 1 | 2014 | 39 | 0.140 |
Why?
|
| Chemokines, CC | 1 | 2014 | 25 | 0.140 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1995 | 76 | 0.140 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2012 | 150 | 0.140 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 923 | 0.140 |
Why?
|
| Mice | 4 | 2021 | 8933 | 0.140 |
Why?
|
| Surface Plasmon Resonance | 3 | 2014 | 33 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2008 | 595 | 0.130 |
Why?
|
| Molecular Sequence Data | 5 | 2014 | 1983 | 0.130 |
Why?
|
| Lymphocyte Activation | 3 | 2012 | 748 | 0.130 |
Why?
|
| Animals | 6 | 2021 | 17767 | 0.130 |
Why?
|
| Double-Blind Method | 5 | 2002 | 561 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2012 | 71 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 665 | 0.120 |
Why?
|
| Pain Measurement | 4 | 2002 | 277 | 0.120 |
Why?
|
| Pain, Postoperative | 2 | 2008 | 103 | 0.120 |
Why?
|
| HLA-A2 Antigen | 2 | 2008 | 69 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2014 | 256 | 0.110 |
Why?
|
| Kinetics | 3 | 2011 | 733 | 0.110 |
Why?
|
| Carbon Dioxide | 1 | 1990 | 63 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2015 | 677 | 0.110 |
Why?
|
| Nerve Block | 2 | 2008 | 25 | 0.100 |
Why?
|
| Bacterial Proteins | 1 | 1996 | 709 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2011 | 80 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 2011 | 179 | 0.100 |
Why?
|
| Mutation | 4 | 2020 | 2188 | 0.100 |
Why?
|
| Delivery, Obstetric | 1 | 1989 | 44 | 0.100 |
Why?
|
| HLA-A Antigens | 1 | 2008 | 14 | 0.090 |
Why?
|
| CD8 Antigens | 1 | 2008 | 59 | 0.090 |
Why?
|
| Circumcision, Male | 1 | 2008 | 10 | 0.090 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2008 | 22 | 0.090 |
Why?
|
| Hernia, Inguinal | 1 | 2008 | 27 | 0.090 |
Why?
|
| Tissue Distribution | 2 | 2020 | 255 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 253 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2014 | 359 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 944 | 0.080 |
Why?
|
| Anesthesia, Caudal | 1 | 2006 | 9 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 97 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 667 | 0.080 |
Why?
|
| Respiratory System | 1 | 2006 | 36 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2006 | 65 | 0.080 |
Why?
|
| Bronchoscopy | 1 | 2006 | 48 | 0.080 |
Why?
|
| Trachea | 1 | 2006 | 65 | 0.080 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 103 | 0.080 |
Why?
|
| Microchemistry | 1 | 2005 | 2 | 0.080 |
Why?
|
| Antibody Affinity | 1 | 2005 | 19 | 0.080 |
Why?
|
| Directed Molecular Evolution | 1 | 2005 | 9 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2007 | 1069 | 0.070 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2005 | 44 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2006 | 313 | 0.070 |
Why?
|
| Antibody Formation | 1 | 2005 | 113 | 0.070 |
Why?
|
| Protein Engineering | 1 | 2005 | 68 | 0.070 |
Why?
|
| Teaching | 1 | 2004 | 161 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 385 | 0.060 |
Why?
|
| HIV-1 | 1 | 2008 | 685 | 0.060 |
Why?
|
| Hydromorphone | 1 | 2002 | 5 | 0.060 |
Why?
|
| Gravidity | 1 | 2001 | 13 | 0.060 |
Why?
|
| Injections, Spinal | 2 | 1998 | 37 | 0.060 |
Why?
|
| Iodine Radioisotopes | 1 | 2020 | 53 | 0.060 |
Why?
|
| Curriculum | 1 | 2004 | 467 | 0.060 |
Why?
|
| Anesthetics, Combined | 1 | 2000 | 6 | 0.050 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2000 | 2 | 0.050 |
Why?
|
| Dura Mater | 1 | 2000 | 13 | 0.050 |
Why?
|
| Phenylalanine | 1 | 2000 | 27 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2000 | 60 | 0.050 |
Why?
|
| Ion Channel Gating | 1 | 2000 | 37 | 0.050 |
Why?
|
| Adult | 5 | 2002 | 13274 | 0.050 |
Why?
|
| Gastrointestinal Contents | 1 | 1998 | 7 | 0.050 |
Why?
|
| Pneumonia, Aspiration | 1 | 1998 | 15 | 0.050 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1998 | 103 | 0.040 |
Why?
|
| Middle Aged | 4 | 2001 | 13594 | 0.040 |
Why?
|
| Coenzyme A | 1 | 1996 | 6 | 0.040 |
Why?
|
| Carbohydrate Sequence | 1 | 1996 | 22 | 0.040 |
Why?
|
| Rats | 1 | 2000 | 1800 | 0.040 |
Why?
|
| Crystallization | 1 | 1996 | 88 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 1997 | 146 | 0.040 |
Why?
|
| Radiography, Panoramic | 1 | 1995 | 3 | 0.040 |
Why?
|
| Mandible | 1 | 1995 | 11 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 1996 | 283 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 1995 | 82 | 0.040 |
Why?
|
| Rhipicephalus sanguineus | 1 | 2014 | 1 | 0.040 |
Why?
|
| Chemokine CCL3 | 1 | 2014 | 8 | 0.040 |
Why?
|
| Chemokine CCL8 | 1 | 2014 | 5 | 0.040 |
Why?
|
| Immunoglobulin Fragments | 1 | 2014 | 8 | 0.040 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 33 | 0.040 |
Why?
|
| Chemotaxis | 1 | 2014 | 43 | 0.040 |
Why?
|
| Heterografts | 1 | 2014 | 57 | 0.040 |
Why?
|
| Glycosylation | 1 | 2014 | 134 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2014 | 226 | 0.030 |
Why?
|
| Morphine | 1 | 1994 | 47 | 0.030 |
Why?
|
| Bone Density | 1 | 1995 | 158 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1995 | 559 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2014 | 59 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2008 | 2035 | 0.030 |
Why?
|
| Gene Expression | 1 | 1996 | 773 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 642 | 0.030 |
Why?
|
| Cell Movement | 1 | 2014 | 388 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 1995 | 881 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 1994 | 216 | 0.030 |
Why?
|
| Leukocyte Immunoglobulin-like Receptor B1 | 1 | 2011 | 1 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2011 | 53 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2012 | 492 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2011 | 76 | 0.030 |
Why?
|
| Biological Assay | 1 | 2011 | 64 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 129 | 0.030 |
Why?
|
| Aged | 3 | 1995 | 10876 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2012 | 560 | 0.030 |
Why?
|
| Infant | 2 | 2008 | 1352 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 156 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2012 | 329 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2011 | 196 | 0.020 |
Why?
|
| MART-1 Antigen | 1 | 2008 | 5 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2008 | 62 | 0.020 |
Why?
|
| Male | 3 | 2008 | 23318 | 0.020 |
Why?
|
| Injections | 1 | 2008 | 74 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1776 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2007 | 101 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2007 | 159 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2007 | 125 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 333 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2007 | 172 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 242 | 0.020 |
Why?
|
| Adolescent | 2 | 1998 | 5487 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 259 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 520 | 0.020 |
Why?
|
| United States | 1 | 1997 | 6122 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2007 | 736 | 0.020 |
Why?
|
| Child | 2 | 2006 | 3762 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 232 | 0.020 |
Why?
|
| Apgar Score | 1 | 2002 | 9 | 0.020 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2002 | 15 | 0.020 |
Why?
|
| Gastric Acidity Determination | 1 | 1998 | 6 | 0.010 |
Why?
|
| Esophageal Diseases | 1 | 1998 | 13 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1998 | 2474 | 0.010 |
Why?
|
| Fasting | 1 | 1998 | 45 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 1998 | 35 | 0.010 |
Why?
|
| Conscious Sedation | 1 | 1998 | 41 | 0.010 |
Why?
|
| Stomach | 1 | 1998 | 55 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1998 | 74 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2006 | 4278 | 0.010 |
Why?
|
| Leg | 1 | 1994 | 78 | 0.010 |
Why?
|
| Elective Surgical Procedures | 1 | 1994 | 105 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1998 | 1774 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 745 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1994 | 1029 | 0.010 |
Why?
|
| Risk Factors | 1 | 1998 | 4205 | 0.010 |
Why?
|